Compare · CELZ vs NU
CELZ vs NU
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Nu Holdings Ltd. (NU): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and NU operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- NU is the larger of the two at $70.46B, about 8286.6x CELZ ($8.5M).
- NU has been more active in the news (5 items in the past 4 weeks vs 1 for CELZ).
- NU has more recent analyst coverage (25 ratings vs 1 for CELZ).
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Nu Holdings Ltd.
Nu Holdings Ltd. operates in the technology industry. The company was incorporated in 2016 and is based in Grand Cayman, Cayman Islands.
Latest CELZ
- Amendment: SEC Form 10-K/A filed by Creative Medical Technology Holdings Inc.
- SEC Form 10-K filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
- Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
- Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
- SEC Form 424B3 filed by Creative Medical Technology Holdings Inc.
- SEC Form EFFECT filed by Creative Medical Technology Holdings Inc.
Latest NU
- SEC Form 3 filed by new insider Piacentini Diego
- SEC Form 4 filed by Fragelli Henrique Camossa Saldanha
- SEC Form 6-K filed by Nu Holdings Ltd.
- Notice to the Market: Nu Holdings Ltd.
- SEC Form 20-F filed by Nu Holdings Ltd.
- SEC Form 4 filed by Junqueira Cristina Helena Zingaretti
- Nu Holdings upgraded by UBS with a new price target
- SEC Form 3 filed by Nu Holdings Ltd.
- SEC Form 3 filed by new insider Lago Guilherme Marques
- SEC Form 3 filed by new insider Fragelli Henrique Camossa Saldanha